Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy

Jana Krynsky

doi:doi:10.11648/j.ijpc.20210706.12

| Peer-Reviewed

Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy

Jana Krynsky

Published in International Journal of Pharmacy and Chemistry (Volume 7, Issue 6)

Received: 29 December 2020 Accepted: 16 January 2021 Published: 29 December 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

The presented case is based on the work of auditing doctor of health insurance company based on data from general practitioners and specialist in pneumology asking for payment an expensive medication. The role of supervision is to access the necessity and justification of costly treatment or to draw the attention of physicians to critical situations of the client and their appropriate solution not only focusing on pharmacology. Monitoring lifelong treatment revealed several key points to significantly affect health that were not properly treated, and this led to disability and, more recently, high treatment costs at later date. The patient's main critical situations have been linked to stress and anxiety but apart from the isolated intervention of a general practitioner, this fact was no considered, not even by specialists. Bronchial asthma is an inflammatory process, and it is known that psychosocial factors play important role as initiators and modifying factors. Their action may affect measurable values of the disease, self-monitoring of the symptoms and adherence for therapy. Not only the pharmacotherapy, but psychological care and strengthening mental health also plays an important role to improve patient well-being. The patient should be viewed in a complex way and early appropriate intervention in risk factors may prevent loss of working potential and economic loss in costly medication.

Published in	International Journal of Pharmacy and Chemistry (Volume 7, Issue 6)
DOI	10.11648/j.ijpc.20210706.12
Page(s)	118-121
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

Bronchial Asthma, Eosinophilia, Stress Factors, Depression, Anxiety, Work Ability, Corticosteroids, Mepolizumab

References

[1]	Terl M. et all. Asthma management: A new phenotype-based approach using presence of eosinophils and allergy, European Journal of allergy and Clinical Immunology 2017, 72 (9) 95-75.
[2]	Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet LP, Brightling C, Chanez P, Dahlen SE, Djukanovic R, Frey U, Gaga M, Gibson P, Hamid Q, Jajour NN, Mauad T, Sorkness RL, Teague WG.: International ERS/ATS guidelines od definition, evaluation and treatment of severe asthma, Eur Respir J. 2014 Feb; 43 (2): 343-73.
[3]	Bourdin, Bjermer, Brightling, Brusselle, Chanez, Chung, Custovic, Diamant, Diver, Djukanovic, Hamerlijnck, Horváth, S. L. Johnston, Kanniess, Papadopoulos, Papi, R. J. Russell, Ryan, Samitas, Tonia, Zervas, Gaga ERS/EAACI statement on severe exacerbations in asthma in adults’ facts, priorities and key research questions European respiratory Journal 2019 554: 1900900.
[4]	Global Initiative for Asthma. Global strategy for asthma management and prevention. https://ginasthma.org/wp-content/uploads/2019/06/GINA-2019-main-report-June-2019-wms.pdf.
[5]	Al-Zahrani JM, Ahmad A, Al-Harbi et al.: Factors associated with poor asthma control in the outpatient clinic setting, April 2015 Annals of Thoracic Medicine 10 (2): 100-4.
[6]	Adams, Wilson, Taylor, Daly, Tursan d´Espaignet´, Ruffin: Psychological factors and asthma guality of life: a population-based study, Thorax 2004.
[7]	Van Lieshout RJ, Macqueen G: Psychosocial factors in asthma, Allergy Asthma Clin. Immunology 4, 1: 12-28, 2008.
[8]	Balardini, Sicuro, Balbi, Canonica, Braid: Psychological aspect in asthma: do psychological factors affect asthma management? Asthma Research and Practice 2015, 1: 7.
[9]	Kelsey J. Sharrad, Olatokunbo Sanwo, Kristin V Carson-Chahhoud, Katharine C Pike: Psychological interventions for asthma in children and adolescents Cochrane Database syst. Rev. 2019 Sep, 209 (9).
[10]	Barnes PJ: Severe asthma: advances in current management and future therapy. J Allergy Clin Immunol 2012; 129 /1ú: 48-59u.
[11]	Corrado Pelaila, C. Crimi, A. Vatrella, C. Tinello, R. Terracciano, Girolamo Pelaila: Molecular Targets for Biological Therapies of Severe Asthma, Front Immunol 2020 Novc 30: 11: 603312.
[12]	Ortega H. G et al.: Mepolizumab Treatment in patients with Seevere Eosinophiic Asthma N Engl J Med 2015; 372: 1777.
[13]	Humbert Marc et al.: Efect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility. Respir Med. Jul-Aug 2019; 154: 69-75.
[14]	Lehrer, Feldman, Song and Schmaling: Psychological Aspects of Asthma, Journal of Consulting and Clinical Psychology 2002, Vol. 70, No 3, 691-711.
[15]	Foster, Lavoie, Boulet: Treatment Adherence and Psychosocial factors in Severe Asthma, European Respiratory Monograph, pp 28-49, March 2011.

Cite This Article

Plain Text BibTeX RIS

APA Style

Jana Krynsky. (2021). Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy. International Journal of Pharmacy and Chemistry, 7(6), 118-121. https://doi.org/10.11648/j.ijpc.20210706.12

Copy | Download

ACS Style

Jana Krynsky. Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy. Int. J. Pharm. Chem. 2021, 7(6), 118-121. doi: 10.11648/j.ijpc.20210706.12

Copy | Download

AMA Style

Jana Krynsky. Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy. Int J Pharm Chem. 2021;7(6):118-121. doi: 10.11648/j.ijpc.20210706.12

Copy | Download

@article{10.11648/j.ijpc.20210706.12,
  author = {Jana Krynsky},
  title = {Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy},
  journal = {International Journal of Pharmacy and Chemistry},
  volume = {7},
  number = {6},
  pages = {118-121},
  doi = {10.11648/j.ijpc.20210706.12},
  url = {https://doi.org/10.11648/j.ijpc.20210706.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijpc.20210706.12},
  abstract = {The presented case is based on the work of auditing doctor of health insurance company based on data from general practitioners and specialist in pneumology asking for payment an expensive medication. The role of supervision is to access the necessity and justification of costly treatment or to draw the attention of physicians to critical situations of the client and their appropriate solution not only focusing on pharmacology. Monitoring lifelong treatment revealed several key points to significantly affect health that were not properly treated, and this led to disability and, more recently, high treatment costs at later date. The patient's main critical situations have been linked to stress and anxiety but apart from the isolated intervention of a general practitioner, this fact was no considered, not even by specialists. Bronchial asthma is an inflammatory process, and it is known that psychosocial factors play important role as initiators and modifying factors. Their action may affect measurable values of the disease, self-monitoring of the symptoms and adherence for therapy. Not only the pharmacotherapy, but psychological care and strengthening mental health also plays an important role to improve patient well-being. The patient should be viewed in a complex way and early appropriate intervention in risk factors may prevent loss of working potential and economic loss in costly medication.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy
AU  - Jana Krynsky
Y1  - 2021/12/29
PY  - 2021
N1  - https://doi.org/10.11648/j.ijpc.20210706.12
DO  - 10.11648/j.ijpc.20210706.12
T2  - International Journal of Pharmacy and Chemistry
JF  - International Journal of Pharmacy and Chemistry
JO  - International Journal of Pharmacy and Chemistry
SP  - 118
EP  - 121
PB  - Science Publishing Group
SN  - 2575-5749
UR  - https://doi.org/10.11648/j.ijpc.20210706.12
AB  - The presented case is based on the work of auditing doctor of health insurance company based on data from general practitioners and specialist in pneumology asking for payment an expensive medication. The role of supervision is to access the necessity and justification of costly treatment or to draw the attention of physicians to critical situations of the client and their appropriate solution not only focusing on pharmacology. Monitoring lifelong treatment revealed several key points to significantly affect health that were not properly treated, and this led to disability and, more recently, high treatment costs at later date. The patient's main critical situations have been linked to stress and anxiety but apart from the isolated intervention of a general practitioner, this fact was no considered, not even by specialists. Bronchial asthma is an inflammatory process, and it is known that psychosocial factors play important role as initiators and modifying factors. Their action may affect measurable values of the disease, self-monitoring of the symptoms and adherence for therapy. Not only the pharmacotherapy, but psychological care and strengthening mental health also plays an important role to improve patient well-being. The patient should be viewed in a complex way and early appropriate intervention in risk factors may prevent loss of working potential and economic loss in costly medication.
VL  - 7
IS  - 6
ER  -

Copy | Download

Author Information

Jana Krynsky

General Health Insurance Company of Czech Republic, Prague, Czech Republic

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Jana Krynsky. (2021). Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy. International Journal of Pharmacy and Chemistry, 7(6), 118-121. https://doi.org/10.11648/j.ijpc.20210706.12

Copy | Download

ACS Style

Jana Krynsky. Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy. Int. J. Pharm. Chem. 2021, 7(6), 118-121. doi: 10.11648/j.ijpc.20210706.12

Copy | Download

AMA Style

Jana Krynsky. Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy. Int J Pharm Chem. 2021;7(6):118-121. doi: 10.11648/j.ijpc.20210706.12

Copy | Download

@article{10.11648/j.ijpc.20210706.12,
  author = {Jana Krynsky},
  title = {Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy},
  journal = {International Journal of Pharmacy and Chemistry},
  volume = {7},
  number = {6},
  pages = {118-121},
  doi = {10.11648/j.ijpc.20210706.12},
  url = {https://doi.org/10.11648/j.ijpc.20210706.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijpc.20210706.12},
  abstract = {The presented case is based on the work of auditing doctor of health insurance company based on data from general practitioners and specialist in pneumology asking for payment an expensive medication. The role of supervision is to access the necessity and justification of costly treatment or to draw the attention of physicians to critical situations of the client and their appropriate solution not only focusing on pharmacology. Monitoring lifelong treatment revealed several key points to significantly affect health that were not properly treated, and this led to disability and, more recently, high treatment costs at later date. The patient's main critical situations have been linked to stress and anxiety but apart from the isolated intervention of a general practitioner, this fact was no considered, not even by specialists. Bronchial asthma is an inflammatory process, and it is known that psychosocial factors play important role as initiators and modifying factors. Their action may affect measurable values of the disease, self-monitoring of the symptoms and adherence for therapy. Not only the pharmacotherapy, but psychological care and strengthening mental health also plays an important role to improve patient well-being. The patient should be viewed in a complex way and early appropriate intervention in risk factors may prevent loss of working potential and economic loss in costly medication.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Importance of Psychosocial Factors in Evaluating the Degree of Bronchial Asthma and for Purposeful Pharmacotherapy
AU  - Jana Krynsky
Y1  - 2021/12/29
PY  - 2021
N1  - https://doi.org/10.11648/j.ijpc.20210706.12
DO  - 10.11648/j.ijpc.20210706.12
T2  - International Journal of Pharmacy and Chemistry
JF  - International Journal of Pharmacy and Chemistry
JO  - International Journal of Pharmacy and Chemistry
SP  - 118
EP  - 121
PB  - Science Publishing Group
SN  - 2575-5749
UR  - https://doi.org/10.11648/j.ijpc.20210706.12
AB  - The presented case is based on the work of auditing doctor of health insurance company based on data from general practitioners and specialist in pneumology asking for payment an expensive medication. The role of supervision is to access the necessity and justification of costly treatment or to draw the attention of physicians to critical situations of the client and their appropriate solution not only focusing on pharmacology. Monitoring lifelong treatment revealed several key points to significantly affect health that were not properly treated, and this led to disability and, more recently, high treatment costs at later date. The patient's main critical situations have been linked to stress and anxiety but apart from the isolated intervention of a general practitioner, this fact was no considered, not even by specialists. Bronchial asthma is an inflammatory process, and it is known that psychosocial factors play important role as initiators and modifying factors. Their action may affect measurable values of the disease, self-monitoring of the symptoms and adherence for therapy. Not only the pharmacotherapy, but psychological care and strengthening mental health also plays an important role to improve patient well-being. The patient should be viewed in a complex way and early appropriate intervention in risk factors may prevent loss of working potential and economic loss in costly medication.
VL  - 7
IS  - 6
ER  -

Copy | Download